Protein kinase B (Akt) regulation and function in T lymphocytes - PubMed (original) (raw)
Review
Protein kinase B (Akt) regulation and function in T lymphocytes
Doreen Cantrell. Semin Immunol. 2002 Feb.
Abstract
Protein kinase B (PKB) [1-5] is a serine/threonine kinase that is activated by cytokines, antigen receptors, the costimulator CD28 and chemokines in lymphocytes. [6-11] PKB is thus poised to contribute to a variety of immune activation responses. A number of functions have been ascribed to PKB in different cell lineages including the regulation of cell survival, cytokine gene induction and cell cycle progression. In the present article the mechanisms that control PKB activity in T lymphocytes will be reviewed and the function of this kinase in the immune system will be discussed.
Copyright 2002 Academic Press.
Similar articles
- p21ras initiates Rac-1 but not phosphatidyl inositol 3 kinase/PKB, mediated signaling pathways in T lymphocytes.
Genot E, Reif K, Beach S, Kramer I, Cantrell D. Genot E, et al. Oncogene. 1998 Oct 1;17(13):1731-8. doi: 10.1038/sj.onc.1202101. Oncogene. 1998. PMID: 9796702 - Ligation of the T cell co-stimulatory receptor CD28 activates the serine-threonine protein kinase protein kinase B.
Parry RV, Reif K, Smith G, Sansom DM, Hemmings BA, Ward SG. Parry RV, et al. Eur J Immunol. 1997 Oct;27(10):2495-501. doi: 10.1002/eji.1830271006. Eur J Immunol. 1997. PMID: 9368602 - Regulation and function of protein kinase B and MAP kinase activation by the IL-5/GM-CSF/IL-3 receptor.
Dijkers PF, van Dijk TB, de Groot RP, Raaijmakers JA, Lammers JW, Koenderman L, Coffer PJ. Dijkers PF, et al. Oncogene. 1999 Jun 3;18(22):3334-42. doi: 10.1038/sj.onc.1202678. Oncogene. 1999. PMID: 10362354 - The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB.
Kandel ES, Hay N. Kandel ES, et al. Exp Cell Res. 1999 Nov 25;253(1):210-29. doi: 10.1006/excr.1999.4690. Exp Cell Res. 1999. PMID: 10579924 Review. - Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling.
Fruman DA. Fruman DA. Curr Opin Immunol. 2004 Jun;16(3):314-20. doi: 10.1016/j.coi.2004.03.014. Curr Opin Immunol. 2004. PMID: 15134780 Review.
Cited by
- The invariant chain CD74 protein is a cell surface binding partner of TIMP-1 in breast cancer cells.
Høeberg M, Noer JB, Vistesen MV, Bartels A, Bech EM, Nygård SB, Lademann U, Stenvang J, Liu S, Fuglsang AT, Brünner N, Moreira JMA. Høeberg M, et al. Mol Oncol. 2023 Aug;17(8):1595-1612. doi: 10.1002/1878-0261.13436. Epub 2023 Apr 28. Mol Oncol. 2023. PMID: 37081824 Free PMC article. - Mechanistic insight of interleukin-9 induced osteoclastogenesis.
Chakraborty S, Schneider J, Mitra DK, Kubatzky KF. Chakraborty S, et al. Immunology. 2023 Jul;169(3):309-322. doi: 10.1111/imm.13630. Epub 2023 Feb 15. Immunology. 2023. PMID: 36732282 Free PMC article. - Akt isoforms in the immune system.
Guerau-de-Arellano M, Piedra-Quintero ZL, Tsichlis PN. Guerau-de-Arellano M, et al. Front Immunol. 2022 Aug 23;13:990874. doi: 10.3389/fimmu.2022.990874. eCollection 2022. Front Immunol. 2022. PMID: 36081513 Free PMC article. Review. - Boosting Akt Pathway by Rupatadine Modulates Th17/Tregs Balance for Attenuation of Isoproterenol-Induced Heart Failure in Rats.
Ahmed LA, Mohamed AF, Abd El-Haleim EA, El-Tanbouly DM. Ahmed LA, et al. Front Pharmacol. 2021 Apr 30;12:651150. doi: 10.3389/fphar.2021.651150. eCollection 2021. Front Pharmacol. 2021. PMID: 33995066 Free PMC article. - Akt3-Mediated Protection Against Inflammatory Demyelinating Disease.
DuBois JC, Ray AK, Gruber RC, Zhang Y, Aflakpui R, Macian-Juan F, Shafit-Zagardo B. DuBois JC, et al. Front Immunol. 2019 Jul 25;10:1738. doi: 10.3389/fimmu.2019.01738. eCollection 2019. Front Immunol. 2019. PMID: 31404142 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous